Principle Research Solutions
Principle Research Solutions
  • Home
  • Current Studies
  • Mission
  • Services
  • More
    • Home
    • Current Studies
    • Mission
    • Services

  • Home
  • Current Studies
  • Mission
  • Services

Escient Pharmaceuticals, Inc.  

Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the

Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects with Atopic Dermatitis

Sign Up/ Request info

ESCIENT Atopic dermatitis

Participation Information

Volunteers needed for up to a 14 week long clinical trial with up to 5 office visits for an investigational product.  $1,250.00 stipend available.  Additional compensation will be available for participants travelling further than 62.1 miles (100 Km).    


To Qualify, you must meet the following INCLUSION CRITERIA:

1.)  18+ years of age (max age = 80)

2.)  Have MILD to MODERATE eczema (atopic dermatitis)

3.)  Minimum of 3% eczema affected body surface area (max 20%) to be determined by Investigator at Screening Visit. 


To Qualify, you must NOT meet the following EXCLUSION CRITERIA:

1.)  Allergic to lidocaine 

2.)  Unwilling to discontinue current atopic dermatitis treatments

3.)  Female who is pregnant or breastfeeding



ClinicalTrials.gov Identifier:  NCT  https://clinicaltrials.gov/study/NCT06144424?cond=Atopic%20Dermatitis&term=escient&rank=1


Escient Pharmaceuticals, Inc Logo

Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Better yet, see us in person!

We love our patients, so feel free to visit during normal business hours.

Principle Research Solutions,llc

510 S Cowley Spokane, WA 99202

(509) 474-1107 MD@principleresearchsolutions.com

Hours

Mon

09:00 am – 05:00 pm

Tue

09:00 am – 05:00 pm

Wed

09:00 am – 05:00 pm

Thu

09:00 am – 05:00 pm

Fri

09:00 am – 05:00 pm

Sat

Closed

Sun

Closed

Photo Gallery

    Copyright © 2025 Principle Research Solutions,llc - All Rights Reserved.


    Powered by

    This website uses cookies.

    We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

    Accept